- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
-
Tremblant Bets on Tech Sector
-
Notable Picks from Investment Managers - Barron's
-
FDA Premarket Approvals: Good Source of Info on Medical Device Companies
-
Wall Street Breakfast: Must-Know News
-
Tracking Cancer Diagnostic and Therapeutic Stocks
-
Capitally Challenged Stocks That Could Be Diluted or Extinguished
-
Hedge Fund Portfolio Tracking: Soros Fund Management (George Soros), Q4 2008
-
Wall Street Breakfast: Must-Know News
-
Trading the Trials and FDA Decision Calendar
-
Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008
-
Stocks Affected by FDA Calendar of Expected Decision Dates
-
Hedge Fund Portfolio Tracking: Renaissance Technologies (Jim Simons), Q3 2008
-
Canaccord Adams on Four Likeliest Economic Scenarios for 2009
-
Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008
-
Hedge Fund Tracking: Bret Barakett's Tremblant Capital, Q3 2008
-
Hologic: A Top Healthcare Pick for 2009?
-
Wall Street Breakfast: Must-Know News
-
Daily Market Outlook: Sharp Losses Expected
-
Battered and Fried - Fast Money Recap (9/12/08)
-
Friday Options Update: MER, AIG, GE, GM, F, XLY, XLP, XME, HSY, MAR, HOLX, CMG
-
Nasdaq 100 Struggles
-
Hedge Fund Tracking: Tremblant Capital
-
Thursday Options Update: MOT, GRA, IP, IBB, CDE, EMC, HOLX
-
Wall Street Breakfast: Must-Know News
-
A Change-of-Pace Growth Strategy
-
Earnings Preview: Hologic
-
Medical Devices: Most Growth Already Priced In
-
HOLX Hoax - Cramer's Lightning Round (5/29/08)
-
Thursday's Options Report: CLX, HOLX, MER, YHOO, HD, HES, BARE, DNR
-
Hologic to Benefit from the Mammography Upgrade Cycle
-
Tuesday's Options Report: GOOG, TSRA, XLF, HD, HOLX, CRDN, USU, AIG
-
Staying Away From Retail, Gadgets
-
Nasdaq 100 Adds Five Companies in Annual Rebalance
-
Ericsson, XMSR Leave Nasdaq; Focus Media, Hansen Among Joiners
-
Investment Opportunities In Healthcare: An Interview With Alan Brochstein
-
Cancer Stocks Hammered Once Again
-
Cancer Stocks Slide Again
-
Cancer Stocks Plunge Following ASCO Meeting
-
Cancer Stocks Soar With Annual ASCO Meeting
-
Cancer Stocks on the Go: Winners and Losers
-
In Swallowing Cytyc, Hologic Paints Too Rosy A Picture